242 related articles for article (PubMed ID: 3781371)
21. [Immunotherapy of melanoma (proceedings)].
Bolund C
Lakartidningen; 1978 Dec; 75(49):4598. PubMed ID: 723350
[No Abstract] [Full Text] [Related]
22. [Treatment of malignant melanoma (author's transl)].
Civatte J; Jourdain JC
MMW Munch Med Wochenschr; 1978 Mar; 120(12):403-6. PubMed ID: 306028
[TBL] [Abstract][Full Text] [Related]
23. [Combined immunotherapy and cytostatic therapy in stage II and III malignant melanoma (proceedings)].
Rundenstam CM
Lakartidningen; 1978 Dec; 75(49):4568-9. PubMed ID: 723339
[No Abstract] [Full Text] [Related]
24. The treatment of malignant melanoma.
Rosin RD
Eur J Surg Oncol; 1985 Jun; 11(2):111-5. PubMed ID: 3891412
[No Abstract] [Full Text] [Related]
25. Malignant melanoma.
Moore GE; Gerner RE
Surg Gynecol Obstet; 1971 Mar; 132(3):427-36. PubMed ID: 5546295
[No Abstract] [Full Text] [Related]
26. Immunotherapy of malignant melanoma.
Terry WD
N Engl J Med; 1980 Nov; 303(20):1174-5. PubMed ID: 6999351
[No Abstract] [Full Text] [Related]
27. Clinical experiences in immunotherapy of cancer.
Krementz ET; Samuels MS; Wallace JH; Benes EN
Surg Gynecol Obstet; 1971 Aug; 133(2):209-17. PubMed ID: 5284416
[No Abstract] [Full Text] [Related]
28. A clinical trial of BCG immunotherapy as an adjunct to surgery in the treatment of primary malignant melanoma.
O'Connor TP; Labandter HP; Hiles RW; Bodenham DC
Br J Plast Surg; 1978 Oct; 31(4):317-22. PubMed ID: 361132
[TBL] [Abstract][Full Text] [Related]
29. [Consensus conference. Follow-up of patients surgically treated for stage I melanoma].
Ann Dermatol Venereol; 1995; 122(5):250-8. PubMed ID: 8572461
[No Abstract] [Full Text] [Related]
30. Treatment of malignant melanoma by intratumoral injection of BCG.
Pinsky CM; Hirshaut Y; Oettgen HF
Natl Cancer Inst Monogr; 1973 Dec; 39():225-8. PubMed ID: 4595322
[No Abstract] [Full Text] [Related]
31. [Immunoreactivity in patients with surgically removed melanoma in the course of BCG vaccination (author's transl)].
Lochman I; Kyselá T; Machálek J; Lochmanová A; Beska F
Cesk Dermatol; 1980; 55(6):372-7. PubMed ID: 7460040
[No Abstract] [Full Text] [Related]
32. [BCG-treatment of malignant melanoma].
Borberg H
Internist (Berl); 1975 Oct; 16(10):482-5. PubMed ID: 1107254
[No Abstract] [Full Text] [Related]
33. Adjuvant therapy for malignant melanoma.
Kaiser LR; Burk MW; Morton DL
Surg Clin North Am; 1981 Dec; 61(6):1249-57. PubMed ID: 7313933
[No Abstract] [Full Text] [Related]
34. [Current aspects of melanoma research. II. Immunotherapy].
Wätzig V
Dermatol Monatsschr; 1977 May; 163(5):359-66. PubMed ID: 881082
[No Abstract] [Full Text] [Related]
35. [Results of adjuvant therapy with the preparation Poly-a Poly-u in patients with malignant melanoma during a 10-year observation].
Pawlicki M; Jońca M; Krzemieniecki K; Zuchowska-Vogelgesang B
Wiad Lek; 1993 Dec; 46(23-24):912-4. PubMed ID: 7900387
[TBL] [Abstract][Full Text] [Related]
36. [Immunotherapy of melanoma].
Dummer R; Nestle FO; Burg G
Dtsch Med Wochenschr; 2000 Oct; 125(41):1240-2. PubMed ID: 11076264
[No Abstract] [Full Text] [Related]
37. [Activity of 2,4 dinitrochlorbenzene skin tests during the course of immunotherapy of malignant melanomas].
Richter J; Duchková H; Kubíková M
Cas Lek Cesk; 1975 Sep; 114(39):1201-3. PubMed ID: 1182748
[No Abstract] [Full Text] [Related]
38. Randomized controlled trial of adjuvant chemoimmunotherapy with DTIC and BCG after complete excision of primary melanoma with a poor prognosis or melanoma metastases.
Can Med Assoc J; 1983 Apr; 128(8):929-33. PubMed ID: 6339024
[TBL] [Abstract][Full Text] [Related]
39. [Immunological aspects of melanoma].
Sjögren H
Lakartidningen; 1976 Feb; 73(7):528-30. PubMed ID: 1250045
[No Abstract] [Full Text] [Related]
40. Adjuvant immunotherapy with BCG in stage II malignant melanoma.
Byrne MJ; Van Hazel G; Reynolds PM; Lemish WM; Holman CD
J Surg Oncol; 1983 Jun; 23(2):114-6. PubMed ID: 6343725
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
